{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:22:22Z","timestamp":1790173342633,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Circulating bone marrow-derived endothelial progenitor cells (EPCs) have been reported to participate in tumor angiogenesis and growth; however, the role of circulating EPCs in tumor progression is controversial. The role of circulating EPCs in ovarian cancer progression and angiogenesis has not yet been investigated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>The number of circulating EPCs in the peripheral blood in 25 healthy volunteers and 42 patients with ovarian cancer was determined by flow cytometry. EPCs were defined by co-expression of CD34 and vascular endothelial growth factor receptor 2 (VEGFR2). In addition, we determined CD34 and VEGFR2 mRNA levels by real-time reverse transcription-polymerase chain reaction. Plasma levels of vascular endothelial growth factor (VEGF) and matrix metalloproteinase-9 (MMP-9) were determined by enzyme-linked immunosorbent assay.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Circulating levels of EPCs were significantly increased in ovarian cancer patients, correlating with tumor stage and residual tumor size. Higher levels of EPCs were detected in patients with stage III and IV ovarian cancer than in patients with stage I and II disease. After excision of the tumor, EPCs levels rapidly declined. Residual tumor size greater than 2 cm was associated with significantly higher levels of EPCs. In addition, high circulating EPCs correlated with poor overall survival. Pretreatment CD34 mRNA levels were not significantly increased in ovarian cancer patients compared with healthy controls; however, VEGFR2 expression was increased, and plasma levels of VEGF and MMP-9 were also elevated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Our results demonstrate the clinical relevance of circulating EPCs in ovarian cancer. EPCs may be a potential biomarker to monitor ovarian cancer progression and angiogenesis and treatment response.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1756-9966-29-27","type":"journal-article","created":{"date-parts":[[2010,3,24]],"date-time":"2010-03-24T19:17:51Z","timestamp":1269458271000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Quantity and clinical relevance of circulating endothelial progenitor cells in human ovarian cancer"],"prefix":"10.1186","volume":"29","author":[{"given":"Yajuan","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,3,24]]},"reference":[{"issue":"6","key":"274_CR1","first-page":"609","volume":"80","author":"MA Roett","year":"2009","unstructured":"Roett MA, Evans P: Ovarian cancer: an overview. Am Fam Physician. 2009, 80 (6): 609-616.","journal-title":"Am Fam Physician"},{"issue":"7","key":"274_CR2","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1634\/theoncologist.2009-0013","volume":"14","author":"S Banerjee","year":"2009","unstructured":"Banerjee S, Gore M: The future of targeted therapies in ovarian cancer. Oncologist. 2009, 14 (7): 706-716. 10.1634\/theoncologist.2009-0013.","journal-title":"Oncologist"},{"issue":"4","key":"274_CR3","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/ncponc1051","volume":"5","author":"WA Spannuth","year":"2008","unstructured":"Spannuth WA, Sood AK, Coleman RL: Angiogenesis as a strategic target for ovarian cancer therapy. Nat Clin Pract Oncol. 2008, 5 (4): 194-204. 10.1038\/ncponc1051.","journal-title":"Nat Clin Pract Oncol"},{"issue":"5","key":"274_CR4","first-page":"601","volume":"23","author":"B Nico","year":"2008","unstructured":"Nico B, Benagiano V, Mangieri D, Maruotti N, Vacca A, Ribatti D: Evaluation of microvascular density in tumors: pro and contra. Histol Histopatho. 2008, 23 (5): 601-607.","journal-title":"Histol Histopatho"},{"issue":"5860","key":"274_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1126\/science.1150224","volume":"319","author":"D Gao","year":"2008","unstructured":"Gao D, Nolan DJ, Mellick AS, Bambino K, McDonnell K, Mittal V: Endothelial Progenitor Cells Control the Angiogenic Switch in Mouse Lung Metastasis. Science. 2008, 319 (5860): 195-198. 10.1126\/science.1150224.","journal-title":"Science"},{"issue":"5","key":"274_CR6","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1159\/000151706","volume":"75","author":"YT Ding","year":"2008","unstructured":"Ding YT, Kumar S, Yu DC: The role of endothelial progenitor cells in tumour vasculogenesis. Pathobiology. 2008, 75 (5): 265-273. 10.1159\/000151706.","journal-title":"Pathobiology"},{"issue":"1","key":"274_CR7","first-page":"33","volume":"1796","author":"D Gao","year":"2009","unstructured":"Gao D, Nolan D, McDonnell K, Vahdat L, Benezra R, Altorki N, Mittal V: Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression. Biochim Biophys Acta. 2009, 1796 (1): 33-40.","journal-title":"Biochim Biophys Acta"},{"issue":"5794","key":"274_CR8","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1126\/science.1127592","volume":"313","author":"Yuval Shaked","year":"2006","unstructured":"Shaked Yuval, Ciarrocchi Alessia, Franco Marcela, Lee Christina, Man Shan, Cheung Alison, Hicklin Daniel, Chaplin David, Foster Stuart, Benezra Robert, Kerbel Robert: Therapy-Induced Acute Recruitment of Circulating Endothelial Progenitor Cells to Tumors. Science. 2006, 313 (5794): 1785-1787. 10.1126\/science.1127592.","journal-title":"Science"},{"issue":"14","key":"274_CR9","doi-asserted-by":"publisher","first-page":"7341","DOI":"10.1158\/0008-5472.CAN-05-4654","volume":"66","author":"J Chane","year":"2006","unstructured":"Chane J, Wang H, Cheu W, Huang S, Liu M, Hsioh J, Yoh K: Identification and Clinical Significance of Circulating Endothelial Progenitor Cells in Human Non-Small Cell Lung Cancer. Cancer Res. 2006, 66 (14): 7341-7347. 10.1158\/0008-5472.CAN-05-4654.","journal-title":"Cancer Res"},{"issue":"4","key":"274_CR10","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/hep.21353","volume":"44","author":"JW Ho","year":"2006","unstructured":"Ho JW, Pang RW, Lau C, Sun CK, Yu WC, Fan ST, Poon RT: Significance of circulating endothelial progenitor cells in hepatocellular carcinoma. Hepatology. 2006, 44 (4): 836-843. 10.1002\/hep.21353.","journal-title":"Hepatology"},{"issue":"3","key":"274_CR11","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10549-007-9505-z","volume":"106","author":"C Christiane Richter-Ehrenstein","year":"2007","unstructured":"Christiane Richter-Ehrenstein C, Rentzsch J, Runkel S, Schneider A, Sch\u00f6nfelder G: Endothelial progenitor cells in breast cancer patients. Breast Cancer Res Treat. 2007, 106 (3): 343-349. 10.1007\/s10549-007-9505-z.","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"274_CR12","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1096\/fj.05-5137fje","volume":"20","author":"B Li","year":"2006","unstructured":"Li B, Sharpe EE, Maupin AB, Teleron AA, Pyle AL, Carmeliet P, Young PP: VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J. 2006, 20 (9): 1495-1497. 10.1096\/fj.05-5137fje.","journal-title":"FASEB J"},{"issue":"4","key":"274_CR13","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/ccd.21292","volume":"70","author":"A Kawamoto","year":"2007","unstructured":"Kawamoto A, Asahara T: Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies. Catheter Cardiovasc Interv. 2007, 70 (4): 477-484. 10.1002\/ccd.21292.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1","key":"274_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s10549-007-9519-6","volume":"107","author":"Hyun Kyung Kim","year":"2008","unstructured":"Kim Kyung Hyun, Song Soon Kyung, Kim Ok Hyun, Chung Jun-Ho, Lee Rhan Kyoung, Lee Young-Joon, Lee Ho Dae, Lee Sook Eun, Kim Kyun Hark, Ryu Won Keun, Bae Jae-Moon: Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer. Breast Cancer Res Treat. 2008, 107 (1): 133-138.","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"274_CR15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3324\/haematol.10723","volume":"92","author":"C Igreja","year":"2007","unstructured":"Igreja C, Courinha M, Cacha\u00e7o AS, Pereira T, Cabe\u00e7adas J, da Silva MG, Dias S: Characterization and clinical relevance of circulating and biopsy-derived endothelial progenitor cells in lymphoma patients. Haematologica. 2007, 92 (4): 469-477. 10.3324\/haematol.10723.","journal-title":"Haematologica"},{"issue":"2","key":"274_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1080\/10623320600697955","volume":"13","author":"M Shibuya","year":"2006","unstructured":"Shibuya M: Vascular endothelial growth factor (VEGF)-Receptor2: its biological functions, major signaling pathway, and specific ligand VEGF-E. Endothelium. 2006, 13 (2): 63-69. 10.1080\/10623320600697955.","journal-title":"Endothelium"},{"issue":"7070","key":"274_CR17","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/nature04479","volume":"438","author":"L Coultas","year":"2005","unstructured":"Coultas L, Chawengsaksophak K, Rossant J: Endothelial cells and VEGF in vascular development. Nature. 2005, 438 (7070): 937-945. 10.1038\/nature04479.","journal-title":"Nature"},{"issue":"11","key":"274_CR18","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/nm1101-1194","volume":"7","author":"D Lyden","year":"2001","unstructured":"Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A: Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med. 2001, 7 (11): 1194-1201. 10.1038\/nm1101-1194.","journal-title":"Nat Med"},{"issue":"8","key":"274_CR19","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1161\/ATVBAHA.109.189175","volume":"29","author":"PH Huang","year":"2009","unstructured":"Huang PH, Chen YH, Wang CH, Chen JS, Tsai HY, Lin FY, Lo WY, Wu TC, Sata M, Chen JW, Lin SJ: Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells. Arterioscler Thromb Vasc Biol. 2009, 29 (8): 1179-1184. 10.1161\/ATVBAHA.109.189175.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"274_CR20","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1158\/1078-0432.CCR-07-1888","volume":"14","author":"TJ Duncan","year":"2008","unstructured":"Duncan TJ, Al-Attar A, Rolland P, Scott IV, Deen S, Liu DT, Spendlove I, Durrant LG: Vascular endothelial growth factor expression in ovarian cancer: a model for targeted use of novel therapies?. Clin Cancer Res. 2008, 14 (10): 3030-3035. 10.1158\/1078-0432.CCR-07-1888.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"274_CR21","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1158\/1078-0432.CCR-06-1008","volume":"13","author":"LA Hefler","year":"2007","unstructured":"Hefler LA, Mustea A, K\u00f6nsgen D, Concin N, Tanner B, Strick R, Heinze G, Grimm C, Schuster E, Tempfer C, Reinthaller A, Zeillinger R: Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancer. Clin Cancer Res. 2007, 13 (3): 898-901. 10.1158\/1078-0432.CCR-06-1008.","journal-title":"Clin Cancer Res"},{"issue":"4C","key":"274_CR22","first-page":"2753","volume":"27","author":"M M\u00e4\u00e4tta","year":"2007","unstructured":"M\u00e4\u00e4tta M, Talvensaari-Mattila A, Turpeenniemi-Hujanen T, Santala M: Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) and their tissue inhibitors (TIMP-1 and TIMP-2) in differential diagnosis between low malignant potential (LMP) and malignant ovarian tumours. Anticancer Res. 2007, 27 (4C): 2753-2758.","journal-title":"Anticancer Res"},{"issue":"1","key":"274_CR23","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1582-4934.2008.00598.x","volume":"13","author":"F Timmermans","year":"2009","unstructured":"Timmermans F, Plum J, Y\u00f6der MC, Ingram DA, Vandekerckhove B, Case J: Endothelial progenitor cells: identity defined?. J Cell Mol Med. 2009, 13 (1): 87-102. 10.1111\/j.1582-4934.2008.00598.x.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"274_CR24","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1038\/nprot.2007.111","volume":"2","author":"DG Duda","year":"2007","unstructured":"Duda DG, Cohen KS, Scadden DT, Jain RK: A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat Protoc. 2007, 2 (4): 805-810. 10.1038\/nprot.2007.111.","journal-title":"Nat Protoc"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-9966-29-27.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T11:51:03Z","timestamp":1630497063000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/1756-9966-29-27"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,24]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["274"],"URL":"https:\/\/doi.org\/10.1186\/1756-9966-29-27","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,24]]},"assertion":[{"value":"26 January 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"27"}}